EIF2AK3 and acute lymphoblastic leukemia: Conversely, targeting endothelial PERK can restore vascular microenvironment function, induce leukemia cell apoptosis, and increase residual hematopoietic progenitor cells, providing a potential therapeutic strategy to improve T-ALL treatment (Liu et al., 2022).